These findings offer a refined perspective on the molecular mechanisms underpinning MLL-associated leukemia, highlighting the potential of ZEB1 and ZEB2 as EMT factors to be critical components within this oncogenic network in AML. This evidence concerns the gene KMT2A and leukemia.